Intellectual property in wildlife genetics

Introduction

Wildlife genetics refers to the study and application of genetic information obtained from wild animals, plants, microorganisms, and other biological resources found in natural ecosystems. It involves DNA sequencing, genetic modification research, population genetics, conservation genetics, genetic databases, and molecular technologies used to understand and protect biodiversity.

Advancements in biotechnology have increased the commercial and scientific value of wildlife genetic resources. Genetic information obtained from endangered species, medicinal organisms, marine biodiversity, and forest ecosystems may be used in pharmaceutical research, conservation programmes, agricultural development, and biotechnology manufacturing.

Intellectual property in wildlife genetics refers to the legal rights associated with inventions, genetic technologies, research processes, biological databases, and commercially valuable genetic information derived from wildlife resources.

However, protecting intellectual property in wildlife genetics creates complex legal questions concerning ownership of genetic resources, biodiversity conservation, traditional knowledge, benefit-sharing, patentability, and the rights of indigenous and local communities.

Meaning and Scope of Intellectual Property in Wildlife Genetics

Intellectual property protection in wildlife genetics involves legal recognition of qualifying scientific inventions and technological innovations developed through the study or utilisation of genetic resources obtained from wildlife.

Major areas include:

Genetic sequencing technologies: Patentable innovations involving specialised DNA analysis and sequencing technologies.

Wildlife genetic databases: Copyright protection for original database structures and contractual protection of confidential information.

Conservation technologies: Innovative genetic monitoring and wildlife identification systems.

Genetic modification techniques: Patentable technological methods involving genetic engineering, subject to statutory exclusions.

Biological discoveries: Scientific findings involving wildlife genetic characteristics, which are not automatically patentable.

Pharmaceutical development: Technological inventions developed through research involving wildlife-derived biological resources.

Genetic research software: Copyright protection for original software used in wildlife genetic analysis.

An important distinction exists between ownership of a biological resource, ownership of information obtained from it, and intellectual property rights over an invention developed through research.

Legal and Regulatory Framework in India

1. Biological Diversity Act, 2002

The Biological Diversity Act, 2002 provides an important legal framework for regulating access to biological resources and associated traditional knowledge.

It promotes:

Conservation of biological diversity.

Sustainable utilisation of biological resources.

Fair and equitable sharing of benefits arising from their utilisation.

The legislation is particularly relevant when wildlife genetic resources are accessed for commercial research and biotechnology development.

The Biological Diversity (Amendment) Act, 2023 introduced changes to the regulatory framework, including certain exemptions and modifications to access and benefit-sharing provisions.

2. Patents Act, 1970

The Patents Act, 1970 regulates patent protection for qualifying technological inventions.

Important provisions include:

Section 2(1)(j): Defines an invention based on novelty, inventive step, and industrial applicability.

Section 3(c): Excludes the mere discovery of a living thing or non-living substance occurring in nature.

Section 3(j): Excludes plants and animals in whole or any part thereof, other than microorganisms, including certain biological subject matter and essentially biological processes.

Section 10: Establishes requirements concerning the contents and disclosure of patent specifications.

Section 25: Provides grounds for opposition to patent applications.

Section 64: Provides grounds for patent revocation.

These provisions are important when determining whether a wildlife genetics-related technological invention qualifies for patent protection.

3. Wildlife (Protection) Act, 1972

The Wildlife (Protection) Act, 1972 provides legal protection to wild animals, plants, and their habitats.

It regulates activities such as hunting, possession, trade, and other dealings involving protected wildlife.

Genetic research involving protected wildlife must comply with applicable wildlife protection requirements. Intellectual property rights cannot independently authorise activities prohibited under wildlife legislation.

4. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides a framework for protecting environmental quality and regulating activities that may cause environmental damage.

It is relevant to wildlife genetics projects involving genetic modification, environmental research, and biological conservation.

5. Convention on Biological Diversity, 1992

The Convention on Biological Diversity establishes three major objectives:

Conservation of biological diversity.

Sustainable use of its components.

Fair and equitable sharing of benefits arising from genetic resources.

India is a party to the Convention, making its principles important for national biodiversity governance.

6. Nagoya Protocol, 2010

The Nagoya Protocol establishes an international framework for access to genetic resources and fair and equitable benefit-sharing.

It is particularly relevant when wildlife genetic resources are accessed for scientific research and commercial biotechnology applications.

Major Intellectual Property Rights in Wildlife Genetics

1. Patent Protection

Patent protection may be available for novel and inventive technologies developed through wildlife genetic research.

For example, a company may develop an innovative genetic analysis instrument or a specialised diagnostic process using wildlife-derived biological information.

However, discovering a naturally occurring gene or genetic characteristic does not automatically create a patentable invention.

2. Trade Secret Protection

Research institutions and biotechnology companies may protect confidential genetic analysis methods, proprietary laboratory processes, and commercially valuable research information through trade secret arrangements.

3. Copyright Protection

Copyright may protect original scientific publications, genetic research software, database structures, and qualifying original compilations.

However, copyright does not ordinarily protect raw facts or genetic information as such.

4. Database Rights and Contracts

India does not have a separate comprehensive sui generis database-right regime equivalent to that of the European Union.

Nevertheless, original database arrangements may receive copyright protection, while access and permitted use may be governed by contracts and applicable data protection requirements.

5. Traditional Knowledge Protection

Wildlife genetics research may overlap with traditional knowledge concerning medicinal plants, animals, and biological resources.

The legal framework seeks to prevent unauthorised exploitation of protected traditional knowledge and promotes appropriate benefit-sharing.

Major Intellectual Property Disputes in Wildlife Genetics

1. Ownership of Genetic Resources

Disputes may arise concerning ownership and control of biological materials collected from forests, wildlife reserves, and other ecosystems.

Researchers, universities, government authorities, and biotechnology companies may disagree about access rights and commercial utilisation.

2. Patent Claims Over Genetic Discoveries

Disputes may arise when companies attempt to patent genetic sequences or biological characteristics discovered in naturally occurring wildlife organisms.

Patent authorities must distinguish genuine technological inventions from discoveries that are excluded under patent legislation.

3. Biopiracy and Unauthorised Commercialisation

Biopiracy refers broadly to the unauthorised appropriation or commercial exploitation of biological resources and associated traditional knowledge.

Such disputes may involve genetic resources collected from local communities or biodiversity-rich ecosystems without satisfying applicable access and benefit-sharing requirements.

4. Benefit-Sharing Disputes

Commercial research using wildlife genetic resources may generate valuable products and technologies.

Disagreements may arise concerning the distribution of benefits between biotechnology companies, government authorities, research institutions, and relevant communities.

5. Research Collaboration Disputes

Universities and biotechnology companies may disagree concerning ownership of genetic databases, research results, patent applications, and commercial licensing rights.

6. International Genetic Resource Disputes

Wildlife genetic resources may be collected in one country and studied or commercialised in another.

This creates questions concerning national sovereignty, access permissions, contractual obligations, and international benefit-sharing rules.

Important Case Laws

1. Divya Pharmacy v. Union of India (2018)

The Uttarakhand High Court examined the applicability of benefit-sharing requirements under the Biological Diversity Act, 2002.

The dispute concerned the obligations of an Indian company commercially utilising biological resources and the legal authority of the biodiversity regulatory framework.

The Court upheld the applicability of the statutory benefit-sharing mechanism in the circumstances considered.

Relevance: The judgment is important for wildlife genetics because biotechnology companies commercially utilising biological resources must consider applicable access and benefit-sharing obligations. Intellectual property protection does not automatically eliminate statutory benefit-sharing responsibilities.

2. Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019)

The Supreme Court examined patent protection involving genetically modified cotton technology and the interaction between patent rights and statutory exclusions under the Patents Act, 1970.

The Court set aside the Delhi High Court's decision and restored the matter for consideration of the infringement suit.

Relevance: The judgment demonstrates the importance of distinguishing patentable technological inventions from excluded biological subject matter. Similar questions may arise in wildlife genetics involving genetically modified organisms and genetic engineering technologies.

3. Novartis AG v. Union of India (2013)

The Supreme Court examined the patentability of a modified form of a known pharmaceutical substance under Section 3(d) of the Patents Act, 1970.

The Court explained that certain modifications to known substances must demonstrate enhanced efficacy to qualify for patent protection.

Relevance: Wildlife genetic research may contribute to pharmaceutical development. The judgment highlights that commercial modifications of known biological or pharmaceutical materials must satisfy applicable patentability requirements.

4. Dimminaco A.G. v. Controller of Patents and Designs (2002)

The Calcutta High Court considered the patentability of a process involving the preparation of a vaccine containing a living organism.

The Court recognised that a process involving living biological material is not automatically excluded from patentability.

Relevance: The decision is significant for wildlife genetics because certain technological processes involving biological materials may qualify for patent protection when statutory conditions are satisfied.

5. T.N. Godavarman Thirumulpad v. Union of India (1996 onwards)

The Supreme Court addressed forest conservation and the protection of ecological resources through continuing judicial supervision.

The proceedings strengthened the legal framework for forest conservation and protection of biodiversity.

Relevance: Wildlife genetics research frequently depends on biological materials obtained from natural ecosystems. Conservation requirements must be respected when collecting or utilising genetic resources. Intellectual property rights cannot justify activities that violate wildlife or forest protection laws.

Role of Government Authorities and Research Institutions

Government authorities and research institutions play an important role in protecting wildlife genetic resources and regulating their commercial utilisation.

Their responsibilities include:

Regulating access to biological resources.

Protecting endangered wildlife species.

Ensuring compliance with biodiversity legislation.

Monitoring commercial utilisation of genetic resources.

Promoting fair and equitable benefit-sharing.

Supporting responsible wildlife genetic research.

Maintaining appropriate research documentation.

Preventing unauthorised commercial exploitation of biological materials.

The National Biodiversity Authority, State Biodiversity Boards, Biodiversity Management Committees, Ministry of Environment, Forest and Climate Change, and relevant wildlife authorities perform important functions within their respective statutory jurisdictions.

Challenges in Protecting Intellectual Property in Wildlife Genetics

Several challenges affect intellectual property protection in this field.

Patentability uncertainty: Naturally occurring genetic information may fall outside patentable subject matter.

Biopiracy: Genetic resources and traditional knowledge may be commercially exploited without appropriate legal permissions.

Ownership conflicts: Disagreements may arise between researchers, governments, communities, and commercial organisations.

International jurisdiction: Different countries apply different laws concerning genetic resources and intellectual property.

Benefit-sharing difficulties: Determining the appropriate distribution of commercial benefits can be complex.

Conservation concerns: Commercial genetic research may create pressure on endangered species and sensitive ecosystems.

Technological development: Rapid advancements in genomic sequencing and synthetic biology create new regulatory challenges.

Recommendations for an Effective Legal Framework

An effective intellectual property framework for wildlife genetics should balance innovation, biodiversity conservation, and community interests.

First, biotechnology companies should conduct legal assessments before accessing wildlife genetic resources.

Second, researchers should obtain applicable permissions and comply with access and benefit-sharing requirements.

Third, patent applications should clearly distinguish technological inventions from naturally occurring biological discoveries.

Fourth, research institutions should establish agreements addressing genetic material ownership, research collaboration, confidentiality, and commercialisation.

Finally, government authorities should strengthen biodiversity monitoring and promote responsible utilisation of wildlife genetic resources.

Conclusion

Intellectual property in wildlife genetics represents an important intersection of biotechnology, patent law, biodiversity conservation, and environmental governance. Scientific developments in genetic sequencing, conservation genetics, and biotechnology have increased the value of wildlife genetic resources and created new opportunities for medical and commercial innovation.

In India, the Biological Diversity Act, 2002, Patents Act, 1970, Wildlife (Protection) Act, 1972, and Environment (Protection) Act, 1986 provide important legal foundations for regulating wildlife genetic research and associated intellectual property rights.

Judicial decisions such as Divya Pharmacy v. Union of India (2018), Monsanto Technology LLC v. Nuziveedu Seeds Ltd. (2019), and Dimminaco A.G. v. Controller of Patents and Designs (2002) establish important principles concerning benefit-sharing, biotechnology patentability, and biological innovation.

Ultimately, an effective legal framework must protect genuine scientific inventions while preventing biopiracy, promoting biodiversity conservation, respecting community interests, and ensuring fair distribution of benefits arising from wildlife genetic resources.

Note: The cited judgments establish broader principles of biodiversity regulation, patentability, and forest conservation. They do not directly determine ownership or patent rights over wildlife genetic sequences.